Literature DB >> 15292338

Effects of estrogen and recombinant human insulin-like growth factor-I on ghrelin secretion in severe undernutrition.

Steven Grinspoon1, Karen K Miller, David B Herzog, Kelly A Grieco, Anne Klibanski.   

Abstract

Ghrelin is a nutritionally regulated gut peptide that increases with fasting and chronic undernutrition and decreases with food intake. Sex steroid levels change in chronic undernutrition and might signal changes in ghrelin. At the same time, chronic undernutrition is characterized by low IGF-I that might also influence ghrelin, either directly or through changes in the GH axis. Little is known regarding sex steroid regulation of ghrelin and the effects of IGF-I on ghrelin in severe undernutrition. We investigated the effects of sex steroids and IGF-I on ghrelin in 78 female subjects with anorexia nervosa simultaneously randomized to receive estrogen (Ovcon 35, 35 microg ethinyl estradiol, and 0.4 mg norethindrone) as well as recombinant human (rh)IGF-I (30 microg/kg sc twice a day) in a two-by-two factorial model, in which the individual effects of estrogen (E) and rhIGF-I on ghrelin could be determined. Subjects were 24.9 +/- 0.7 (mean +/- sem) yr of age and had low weight (body mass index, 16.7 +/- 0.2 kg/m(2)). At baseline, ghrelin was inversely correlated with body mass index (r = -0.39, P = 0.0005) and IGF-I (r = -0.30, P = 0.01). IGF-I increased significantly more in subjects receiving rhIGF-I alone (Delta 23.0 +/- 5.8 nmol/liter) and rhIGF-I and E (Delta 34.9 +/- 6.3 nmol/liter) compared with subjects receiving E alone (Delta -3.2 +/- 1.9 nmol/liter) or control (C; rhIGF-I placebo and no E) (Delta 0.4 +/- 2.0 nmol/liter) (overall P < 0.0001 by multivariate analysis of variance, P < 0.0001 for rhIGF-I vs. C, P < 0.0001 for rhIGF-I and E vs. C). Ghrelin increased significantly more over 6 months in response to E alone (Delta 150 +/- 86 pg/ml), rhIGF-I alone (Delta 198 +/- 116 pg/ml), and the combination (E and rhIGF-I) (Delta 441 +/- 214 pg/ml) compared with C (Delta -39 +/- 48 pg/ml) (overall P = 0.02 by multivariate analysis of variance, P = 0.01 for E vs. C, P = 0.04 for rhIGF-I vs. C, and P = 0.001 for rhIGF-I and E vs. C). Weight, caloric intake, and morning GH levels did not change significantly between the groups, but the change in ghrelin was inversely related to the change in GH among all subjects (r = -0.27, P = 0.03).Our data demonstrate that, in a model of severe undernutrition, rhIGF-I and E individually increase ghrelin levels. The mechanisms of these effects are unknown and may relate to direct effects on ghrelin or changes in GH. Further studies are needed to determine the mechanisms by which rhIGF-I and E increase ghrelin in human physiology.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15292338     DOI: 10.1210/jc.2004-0287

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  12 in total

1.  The effect of estrogens on plasma ghrelin concentrations in women.

Authors:  K Dafopoulos; N Chalvatzas; G Kosmas; A Kallitsaris; S Pournaras; I E Messinis
Journal:  J Endocrinol Invest       Date:  2010-02       Impact factor: 4.256

2.  Abnormal ghrelin secretion contributes to gastrointestinal symptoms in multiple system atrophy patients.

Authors:  Tetsutaro Ozawa; Jun Tokunaga; Musashi Arakawa; Atsushi Ishikawa; Ryoko Takeuchi; Naomi Mezaki; Takeshi Miura; Naoko Sakai; Mariko Hokari; Akari Takeshima; Kota Utsumi; Takashi Kondo; Akio Yokoseki; Masatoyo Nishizawa
Journal:  J Neurol       Date:  2013-05-08       Impact factor: 4.849

3.  Assessment of ghrelin and leptin receptor levels in postmenopausal women who received oral or transdermal menopausal hormonal therapy.

Authors:  Barbara Ruszkowska; Alina Sokup; Arleta Kulwas; Maciej W Socha; Krzysztof Góralczyk; Barbara Góralczyk; Danuta Rość
Journal:  J Zhejiang Univ Sci B       Date:  2012-01       Impact factor: 3.066

4.  Menopausal status influences the relationship between serum ghrelin levels and fat mass in healthy women.

Authors:  I Iwamoto; N Yoshimitsu; T Fujino; T Douchi
Journal:  J Endocrinol Invest       Date:  2005-05       Impact factor: 4.256

5.  Integrating GHS into the Ghrelin System.

Authors:  Johannes D Veldhuis; Cyril Y Bowers
Journal:  Int J Pept       Date:  2010-03-18

6.  Estrogen elevates the peak overnight production rate of acylated ghrelin.

Authors:  Remberto C Paulo; Richard Brundage; Mihaela Cosma; Kristi L Mielke; Cyril Y Bowers; Johannes D Veldhuis
Journal:  J Clin Endocrinol Metab       Date:  2008-08-12       Impact factor: 5.958

7.  Relationships between acylated ghrelin with growth hormone, insulin resistance, lipid profile, and cardio respiratory function in lean and obese men.

Authors:  Hasan Matin Homaee; Fatah Moradi; Mohammad Ali Azarbayjani; Maghsoud Peeri
Journal:  J Res Med Sci       Date:  2011-12       Impact factor: 1.852

8.  Ghrelin cells in the gastrointestinal tract.

Authors:  Ichiro Sakata; Takafumi Sakai
Journal:  Int J Pept       Date:  2010-03-14

Review 9.  Growth hormone axis in chronic kidney disease.

Authors:  Shefali Mahesh; Frederick Kaskel
Journal:  Pediatr Nephrol       Date:  2007-08-05       Impact factor: 3.714

Review 10.  Growth retardation in children with kidney disease.

Authors:  Paulina Salas; Viola Pinto; Josefina Rodriguez; Maria Jose Zambrano; Veronica Mericq
Journal:  Int J Endocrinol       Date:  2013-09-25       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.